Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
crispr
2
×
editas medicine
life sciences
national blog main
2
×
allergan
biotech
boston
cancer
clinical trials
crispr therapeutics
crispr-cas9
cynthia collins
drugs
editas
gene editing
intellia therapeutics
katrine bosley
leber congenital amaurosis
national
national top stories
p53
san francisco blog main
san francisco top stories
What
crispr
editing
2
×
gene
medicine
2
×
allergan
blessing
bosley
cancer
cas
cells
ceo
check
clinical
cusp
defect
depart
drive
editas
edited
experimental
fears
flag
genetic
guardian
human
humans
katrine
known
lab
malfunction
million
nature
new
nicknamed
occurs
papers
partner
potential
published
raising
Language
Current search:
medicine
×
crispr
×
" national blog main "
×
editing
×
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
@xconomy.com
6 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells